Litigation Details for Takeda Pharmaceuticals U.S.A. v. Hikma Americas Inc. (Fed. Cir. 2014)
✉ Email this page to a colleague
Takeda Pharmaceuticals U.S.A. v. Hikma Americas Inc. (Fed. Cir. 2014)
| Docket | ⤷ Try a Trial | Date Filed | 2014-11-06 |
| Court | Court of Appeals for the Federal Circuit | Date Terminated | |
| Cause | Assigned To | ||
| Jury Demand | Referred To | ||
| Patents | 6,037,157; 7,601,758; 7,619,004; 7,820,681; 7,906,519; 7,915,269; 7,935,731; 7,964,647; 7,964,648; 7,981,938; 8,093,296; 8,093,297; 8,097,655; 8,440,722 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Takeda Pharmaceuticals U.S.A. v. Hikma Americas Inc.
The small molecule drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for Takeda Pharmaceuticals U.S.A. v. Hikma Americas Inc. (Fed. Cir. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2014-11-23 | 32 | A 1/2000 TeagaJCden et al. 6,037,157 A 3/2000 Norbeck et al. …5,968,972 A 10/1999 Broder et al. 6,037.157 A 3/2000 Norbeck ct al. …. Such methods reduce the dangers com- 6,037,157 A 3/2000 Norbeck et al. …;655 patent), ketoconazole ('648 patent), or verapamil ('722 patent). The '938 patent is directed…655 patent), ketoconazole ('648 patent) , or verapamil ('722 patent). The '938 patent is directed | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
